Alliance Pharma (LON:APH) Reaches New 12-Month High – Time to Buy?

Alliance Pharma plc (LON:APH) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 62.20 ($0.78) and last traded at GBX 61.30 ($0.77), with a volume of 819424 shares changing hands. The stock had previously closed at GBX 61.50 ($0.77).

Analyst Ratings Changes

Separately, Berenberg Bank cut Alliance Pharma to a “hold” rating and cut their price target for the stock from GBX 7,000 ($88.08) to GBX 6,250 ($78.65) in a report on Wednesday, January 29th.

Alliance Pharma Price Performance

The company has a debt-to-equity ratio of 46.27, a current ratio of 2.93 and a quick ratio of 1.42. The firm has a market capitalization of £324.70 million, a price-to-earnings ratio of -9.67, a PEG ratio of 1.04 and a beta of 0.67. The business’s fifty day simple moving average is GBX 54.65 and its 200 day simple moving average is GBX 46.66.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.